X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (22999) 22999
Publication (3404) 3404
Book Review (3348) 3348
Book Chapter (215) 215
Newspaper Article (210) 210
Newsletter (152) 152
Conference Proceeding (91) 91
Book / eBook (29) 29
Dissertation (16) 16
Magazine Article (8) 8
Reference (7) 7
Government Document (3) 3
Web Resource (3) 3
Data Set (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (20521) 20521
chromatin (12254) 12254
humans (12125) 12125
animals (10957) 10957
biochemistry & molecular biology (5535) 5535
cell biology (5431) 5431
gene expression (5298) 5298
mice (4954) 4954
proteins (4114) 4114
chromatin - metabolism (3931) 3931
cancer (3791) 3791
male (3769) 3769
histones - metabolism (3556) 3556
dna (3327) 3327
female (3283) 3283
research (3158) 3158
dna methylation (3148) 3148
epigenetics (3110) 3110
transcription (3108) 3108
genes (2968) 2968
chromatin immunoprecipitation (2958) 2958
apoptosis (2948) 2948
gene-expression (2925) 2925
oncology (2864) 2864
expression (2861) 2861
cell line, tumor (2795) 2795
genetic aspects (2691) 2691
methylation (2666) 2666
article (2637) 2637
analysis (2495) 2495
deoxyribonucleic acid--dna (2477) 2477
multidisciplinary sciences (2377) 2377
acetylation (2333) 2333
research article (2263) 2263
rats (2208) 2208
cell line (2196) 2196
genetics & heredity (2065) 2065
chromatin - drug effects (2040) 2040
biology (1950) 1950
protein binding (1904) 1904
cells (1892) 1892
cells, cultured (1857) 1857
medicine (1847) 1847
genetics (1835) 1835
dna damage (1812) 1812
genomes (1808) 1808
physiological aspects (1783) 1783
promoter regions, genetic (1772) 1772
histones (1756) 1756
transcription factors (1751) 1751
activation (1729) 1729
cell cycle (1710) 1710
phosphorylation (1667) 1667
signal transduction (1635) 1635
science (1634) 1634
mutation (1620) 1620
genomics (1579) 1579
transcription, genetic (1534) 1534
transcription factors - metabolism (1491) 1491
genetic transcription (1474) 1474
binding sites (1432) 1432
epigenetic inheritance (1430) 1430
epigenesis, genetic (1408) 1408
blotting, western (1350) 1350
chromatin - genetics (1341) 1341
apoptosis - drug effects (1317) 1317
kinases (1316) 1316
biochemistry (1310) 1310
rna (1307) 1307
immunoprecipitation (1306) 1306
molecular biology (1304) 1304
health aspects (1302) 1302
gene expression regulation (1254) 1254
in-vivo (1226) 1226
cell nucleus - metabolism (1194) 1194
differentiation (1180) 1180
binding (1176) 1176
enzymes (1168) 1168
protein (1164) 1164
reverse transcriptase polymerase chain reaction (1136) 1136
deoxyribonucleic acid (1132) 1132
dna repair (1126) 1126
transcription, genetic - drug effects (1122) 1122
neurosciences (1119) 1119
dna-binding proteins - metabolism (1105) 1105
gene regulation (1089) 1089
gene (1084) 1084
base sequence (1078) 1078
stem cells (1068) 1068
dna - metabolism (1060) 1060
molecular sequence data (1056) 1056
tumors (1049) 1049
rodents (1042) 1042
genetic research (1035) 1035
time factors (1034) 1034
chromatin - ultrastructure (1033) 1033
promoter regions, genetic - genetics (1029) 1029
histone deacetylase (1019) 1019
transcription factors - genetics (1019) 1019
cell proliferation (1009) 1009
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (23095) 23095
Russian (275) 275
French (37) 37
German (30) 30
Japanese (14) 14
Chinese (11) 11
Spanish (8) 8
Polish (7) 7
Ukrainian (6) 6
Bulgarian (3) 3
Italian (3) 3
Korean (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 01/2016, Volume 529, Issue 7586, pp. 413 - 417
Triple-negative breast cancer (TNBC) is a heterogeneous and clinically aggressive disease for which there is no targeted therapy(1-3). BET bromodomain... 
SELECTIVE-INHIBITION | SUPER-ENHANCERS | RNA-SEQ | SUBTYPES | INFLAMMATION | STRATEGY | MULTIDISCIPLINARY SCIENCES | CELL IDENTITY | C-MYC | PP2A | LEUKEMIA | Chromatin - metabolism | Transcription, Genetic - drug effects | Humans | Transcription Factors - deficiency | Triple Negative Breast Neoplasms - drug therapy | Genome, Human - drug effects | Nuclear Proteins - deficiency | Protein Binding - drug effects | Triple Negative Breast Neoplasms - pathology | Female | Epigenesis, Genetic - drug effects | Gene Expression Regulation, Neoplastic - drug effects | Phosphorylation - drug effects | Nuclear Proteins - genetics | Triazoles - therapeutic use | Cell Proliferation - genetics | Mediator Complex Subunit 1 - metabolism | Nuclear Proteins - metabolism | Transcription Factors - antagonists & inhibitors | Transcription Factors - genetics | Phosphoserine - metabolism | Genome, Human - genetics | Azepines - therapeutic use | Azepines - pharmacology | Binding, Competitive - drug effects | Transcription Factors - metabolism | Triazoles - pharmacology | Xenograft Model Antitumor Assays | Drug Resistance, Neoplasm - genetics | Animals | Triple Negative Breast Neoplasms - genetics | Epigenesis, Genetic - genetics | Triple Negative Breast Neoplasms - metabolism | Nuclear Proteins - antagonists & inhibitors | Protein Phosphatase 2 - metabolism | Proteomics | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Chromatin - genetics | Casein Kinase II - metabolism | Drug Resistance, Neoplasm - drug effects | Protein Structure, Tertiary - drug effects | Antimitotic agents | Enzyme inhibitors | Patient outcomes | Breast cancer | Dosage and administration | Drug therapy | Antineoplastic agents | Studies | Inhibitor drugs | Drug resistance | Gene expression | Drug dosages | Index Medicus
Journal Article
Nature, ISSN 0028-0836, 06/2017, Volume 546, Issue 7658, pp. 431 - 435
Therapies that target signalling molecules that are mutated in cancers can often have substantial short-term effects, but the emergence of resistant cancer... 
METASTATIC MELANOMA | BRAF INHIBITOR | SUBPOPULATIONS | CHROMATIN | MULTIDISCIPLINARY SCIENCES | SINGLE MAMMALIAN-CELLS | STATE | MECHANISMS | MUTATIONS | VEMURAFENIB | PLASTICITY | Transcription, Genetic - drug effects | Humans | Male | Transcription Factor AP-1 - metabolism | DNA-Binding Proteins - metabolism | Melanoma - genetics | Female | Indoles - pharmacology | Epigenesis, Genetic - drug effects | Gene Expression Regulation, Neoplastic - drug effects | SOXE Transcription Factors - deficiency | Single-Cell Analysis | Cellular Reprogramming - genetics | ErbB Receptors - metabolism | In Situ Hybridization, Fluorescence | Nuclear Proteins - metabolism | Signal Transduction - genetics | Melanoma - pathology | Sulfonamides - pharmacology | Cellular Reprogramming - drug effects | Transcription Factors - metabolism | Xenograft Model Antitumor Assays | Genetic Markers - drug effects | Vemurafenib | Drug Resistance, Neoplasm - genetics | Animals | Signal Transduction - drug effects | Genetic Markers - genetics | Cell Line, Tumor | Oncogene Protein p65(gag-jun) - metabolism | Drug Resistance, Neoplasm - drug effects | SOXE Transcription Factors - genetics | Antimitotic agents | Cell interaction | Dosage and administration | Antineoplastic agents | Drug resistance | Observations | Health aspects | Subpopulations | Transcription factors | Substance abuse treatment | Variability | Activator protein 1 | Melanoma | Genomes | Kinases | Gene expression | Sox10 protein | Signal transduction | Signaling | Converting | Population | Mutation | Differentiation | Deoxyribonucleic acid--DNA | Cancer | Index Medicus
Journal Article
Nature, ISSN 0028-0836, 01/2016, Volume 529, Issue 7584, pp. 110 - 114
Gain-of-function IDH mutations are initiating events that define major clinical and prognostic classes of gliomas(1,2). Mutant IDH protein produces a new... 
MAINTENANCE | METHYLATION | LANDSCAPE | DEMETHYLATION | MULTIDISCIPLINARY SCIENCES | INTEGRATED GENOMIC ANALYSIS | ARCHITECTURE | PHENOTYPE | EXPRESSION | 2-HYDROXYGLUTARATE | PRINCIPLES | Chromatin - metabolism | Up-Regulation | Humans | Glioma - genetics | Base Sequence | Glioma - pathology | Epigenesis, Genetic - drug effects | Gene Expression Regulation, Neoplastic - drug effects | Binding Sites | Chromatin - drug effects | Repressor Proteins - metabolism | Oncogenes - genetics | Insulator Elements - genetics | Glioma - enzymology | Chromosomal Proteins, Non-Histone - metabolism | Cell Cycle Proteins - metabolism | Cells, Cultured | Isocitrate Dehydrogenase - genetics | DNA Methylation - genetics | Down-Regulation - drug effects | Mutation - genetics | CRISPR-Cas Systems - genetics | Insulator Elements - drug effects | Phenotype | Isocitrate Dehydrogenase - chemistry | Receptor, Platelet-Derived Growth Factor alpha - genetics | CCCTC-Binding Factor | CpG Islands - genetics | Protein Binding | Isocitrate Dehydrogenase - metabolism | Cell Proliferation - drug effects | Enhancer Elements, Genetic - genetics | Glutarates - metabolism | Cell Transformation, Neoplastic - drug effects | Chromatin - genetics | DNA Methylation - drug effects | Glioma - drug therapy | Complications and side effects | Care and treatment | Platelet-derived growth factor | Gliomas | Analysis | Influence | Genetic aspects | Research | Methylation | Oncogenes | DNA methylation | Epigenetics | Genomes | Mutation | Gene expression | Binding sites | Deoxyribonucleic acid--DNA | Tumors | Index Medicus
Journal Article
Cell Stem Cell, ISSN 1934-5909, 02/2017, Volume 20, Issue 2, pp. 233 - 246.e7
Journal Article
Nature, ISSN 0028-0836, 09/2015, Volume 525, Issue 7570, pp. 538 - 542
Bromodomain and extra terminal protein (BET) inhibitors are first-in-class targeted therapies that deliver a newtherapeutic opportunity by directly targeting... 
SELECTIVE-INHIBITION | ACCURATE | CHROMATIN | MECHANISM | MULTIDISCIPLINARY SCIENCES | ACUTE MYELOID-LEUKEMIA | DRUG-RESISTANCE | MUTATIONS | SEQUENCING DATA | CANCER | DISCOVERY | Chromatin - metabolism | Transcription, Genetic - drug effects | Clone Cells - drug effects | Neoplastic Stem Cells - drug effects | Epigenesis, Genetic | Humans | Leukemia, Myeloid, Acute - metabolism | Molecular Targeted Therapy | Neoplastic Stem Cells - metabolism | Leukemia, Myeloid, Acute - drug therapy | Neoplastic Stem Cells - pathology | Gene Expression Regulation, Neoplastic - drug effects | Hematopoietic Stem Cells - drug effects | Benzodiazepines - pharmacology | Leukemia, Myeloid, Acute - pathology | Cells, Cultured | Nuclear Proteins - metabolism | Transcription Factors - antagonists & inhibitors | Hematopoietic Stem Cells - metabolism | Clone Cells - metabolism | beta Catenin - metabolism | Azepines - pharmacology | Transcription Factors - metabolism | Triazoles - pharmacology | Drug Resistance, Neoplasm - genetics | Animals | Clone Cells - pathology | Wnt Signaling Pathway - drug effects | Genes, myc - genetics | Hematopoietic Stem Cells - cytology | Nuclear Proteins - antagonists & inhibitors | Cell Line, Tumor | Mice | Drug Resistance, Neoplasm - drug effects | Leukemia, Myeloid, Acute - genetics | Proteins | Leukemia | Cloning | Cell cycle | Stem cells | Epigenetics | Apoptosis | Index Medicus
Journal Article
Nature Medicine, ISSN 1078-8956, 04/2017, Volume 23, Issue 4, pp. 493 - 500
Journal Article
by Meng, S and Zhang, L and Tang, Y and Tu, Q and Zheng, L and Yu, L and Murray, D and Cheng, J and Kim, S.H and Zhou, X and Chen, J
Journal of Dental Research, ISSN 0022-0345, 7/2014, Volume 93, Issue 7, pp. 657 - 662
Journal Article
Journal of Leukocyte Biology, ISSN 0741-5400, 12/2012, Volume 92, Issue 6, pp. 1147 - 1154
Journal Article